Dimiracetam in Painful Neuropathies Affecting AIDS Patients
Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and tolerability of orally administered
dimiracetam for 10 weeks to AIDS patients under treatment with antiretroviral agents
presenting a disease and /or treatment related neuropathic pain.